Private equity-backed medical devices maker Biomet is planning to raise $100m via an IPO, according got a document filed with US securities regulators.
Last month it was reported that Biomet had hired Bank of America Merrill Lynch, Goldman Sachs and JPMorgan Chase as underwriters for its IPO.
The company was taken private by Blackstone, Goldman Sachs, KKR and TPG in an $11.4bn deal in 2007.
The IPO could take place in the first half of 2014 and raise more than $1bn, according to Reuters.
Back in 2012 Biomet, which is focused on the orthopaedic and musculoskeletal product industry, paid $22m in charges to settle allegations that it bribed doctors in Argentina, Brazil, and China for nearly a decade to win business.
Copyright © 2014 AltAssets